BCR and benign prostatic hyperplasia: Across all the BPH nodules, B cell repertoires showed high diversity, with few individual BCR clonotypes — defined by shared V-J segments and complementarity-determining region 3 (CDR3) sequences — representing even 1% of the BCR repertoire (Figure 1E).